Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Ptc Therapeutics (PTCT) over the last 10 years, with Q3 2025 value amounting to 4.6%.

  • Ptc Therapeutics' Return on Invested Capital fell 47400.0% to 4.6% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.6%, marking a year-over-year decrease of 47400.0%. This contributed to the annual value of 0.34% for FY2024, which is 4100.0% down from last year.
  • Per Ptc Therapeutics' latest filing, its Return on Invested Capital stood at 4.6% for Q3 2025, which was down 47400.0% from 3.46% recorded in Q2 2025.
  • Ptc Therapeutics' Return on Invested Capital's 5-year high stood at 3.14% during Q2 2022, with a 5-year trough of 9.15% in Q1 2022.
  • In the last 5 years, Ptc Therapeutics' Return on Invested Capital had a median value of 0.21% in 2024 and averaged 0.66%.
  • In the last 5 years, Ptc Therapeutics' Return on Invested Capital crashed by -80200bps in 2022 and then skyrocketed by 104300bps in 2023.
  • Quarter analysis of 5 years shows Ptc Therapeutics' Return on Invested Capital stood at 1.87% in 2021, then soared by 195bps to 1.77% in 2022, then tumbled by -69bps to 0.55% in 2023, then plummeted by -46bps to 0.3% in 2024, then tumbled by -1640bps to 4.6% in 2025.
  • Its last three reported values are 4.6% in Q3 2025, 3.46% for Q2 2025, and 0.92% during Q1 2025.